Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.49 |
| ▸ | VIPR1 | P32241 | 3/20 | 0.46 |
| ▸ | TFPI | P10646 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.45 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.45 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.45 |
| ▸ | NPY2R | P49146 | 7/20 | 0.45 |
| ▸ | NPY4R | P50391 | 7/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.45 |
| ▸ | NPY1R | P25929 | 5/20 | 0.45 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.44 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.43 |
| ▸ | VIPR2 | P41587 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30692438 | 0.96 | TASP1 (0.49) | TASP1VIPR1TFPIGRIN2DGRIN3B | |
| SCHEMBL29416066 | 0.95 | GRIN2D (0.52) | VIPR1TFPIGRIN2DGRIN3BGRIN1 | |
| SCHEMBL29424990 | 0.93 | VIPR1 (0.52) | TASP1VIPR1TFPIGRIN2DGRIN3B | |
| SCHEMBL29805066 | 0.92 | GRIN2D (0.52) | TASP1VIPR1TFPIGRIN2DGRIN3B | |
| SCHEMBL31168167 | 0.89 | ENPEP (0.48) | TASP1VIPR1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL29468197 | 0.89 | VIPR1 (0.50) | TASP1VIPR1TFPIGRIN2DGRIN3B | |
| Fexapotide SCHEMBL29356097 | 0.89 | VIPR1 (0.50) | TASP1VIPR1TFPIGRIN2DGRIN3B | |
| SCHEMBL31491259 | 0.89 | ENPEP (0.46) | KISS1R | |
| SCHEMBL30680476 | 0.87 | ENPEP (0.46) | VIPR1NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31287215 | 0.87 | GRIN2D (0.53) | TASP1VIPR1TFPIGRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110381984-B | Compositions and methods for improving sexual function | 尼莫克斯股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| EP-4275688-A2 | METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH | Nymox Corporation (BS) | 2023-11-15 | — | — | EP | disclosed |
| CN-116785403-A | Neurofilament peptides for preventing or slowing the progression of prostate cancer | 尼莫克斯股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-109310732-B | Neurofilament peptides for preventing or slowing the progression of prostate cancer | 尼莫克斯股份有限公司 | 2023-07-21 | — | — | CN | disclosed |
| US-11628202-B2 | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia | NYMOX CORPORATION (CA) | 2023-04-18 | — | — | US | disclosed |
| CN-114099636-A | Method of treating a condition requiring cell destruction or removal using peptides derived from neurofilament proteins | 尼莫克斯制药公司 | 2022-03-01 | — | — | CN | disclosed |